Black Country Pathology Services has pushed ahead with a major initiative to create a laboratory network to serve four trusts and delivered a successful go-live for its CliniSys laboratory information system despite the coronavirus emergency.
BCPS was formed in response to a report by Lord Carter of Coles, which recommended that NHS laboratory services should be re-organised into a regional 'hub and spoke' model to improve quality and efficiency.
North Bristol NHS Trust has successfully and safely fast-tracked the roll out of a series of digital tools to clinicians to help in their response to COVID-19.
Over 3,500 clinicians went live with the CareFlow instant messaging and care co-ordination app to aid collaboration in and between teams, facilitate electronic handovers and share clinical photos, with more clinical information for patient care in one place to improve decision making.
The university and the company have formed a partnership to enable students to experience OPENeP, learn about the principles of prescribing, dispensing and administering medicines electronically, and explore the patient safety aspects of the technology.
Tampa General Hospital (TGH) and Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced they are creating a long-term strategic partnership designed to keep Tampa General Hospital at the forefront of technological innovation.
Tampa General, one of the largest hospitals in the U.S., will have early and ongoing access to the latest Philips innovations during the seven-year arrangement.
Highland Marketing, a full-service agency for health tech marketing, PR and communications, is recruiting three new account team members to support clients and growth. This is despite the economic and employment challenges brought by COVID-19.
Today, the U.S. Food and Drug Administration announced it is launching the Digital Health Center of Excellence within the Center for Devices and Radiological Health (CDRH). The launch of the Digital Health Center of Excellence is an important step in furthering the agency's overarching dedication to the advancement of digital health technology, including mobile health devices, Software as a Medical Device (SaMD), wearables when used as a medical device, and technologies used to study medical products.
Siemens Healthineers announced today a master collaboration agreement with Novartis Pharma AG to design, develop, and commercialize diagnostic tests for therapeutic products across Novartis' therapeutic pipeline. The initial program supports the development of a serum neurofilament light chain (sNFL) immunoassay to support Novartis’ MS and other neuroscience programs.